Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-26 @ 3:02 AM
Study NCT ID:
NCT03301220
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-23
First Post:
2017-09-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2017-09-29
First Submit QC Date:
None
Study First Post Date:
2017-10-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-12-06
Results First Submit QC Date:
None
Results First Post Date:
2025-12-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-05-01
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-12-06
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED